Have recent tariffs resulted in increased costs for the US health-care system? We examine US trade data and compile a database of statutory tariff changes. Tariffs on medical goods narrowly defined resulted in 3. 4 billion in duties assessed between February and July 2025 — more than 10 times the same period in 2024, with a 55. 8 percent rate of pass-through at the US border. We estimate that had medical goods imports observed in 2024 been subject to the statutory tariff levels prevailing in August 2025, assessed duties would have been 15. 8 billion, almost 30 times higher than those observed in real time.
Kang et al. (Fri,) studied this question.